281 related articles for article (PubMed ID: 26935435)
1. Comparing Alzheimer's and Parkinson's diseases networks using graph communities structure.
Calderone A; Formenti M; Aprea F; Papa M; Alberghina L; Colangelo AM; Bertolazzi P
BMC Syst Biol; 2016 Mar; 10():25. PubMed ID: 26935435
[TBL] [Abstract][Full Text] [Related]
2. Quantifying mechanisms in neurodegenerative diseases (NDDs) using candidate mechanism perturbation amplitude (CMPA) algorithm.
Karki R; Kodamullil AT; Hoyt CT; Hofmann-Apitius M
BMC Bioinformatics; 2019 Oct; 20(1):494. PubMed ID: 31604427
[TBL] [Abstract][Full Text] [Related]
3. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease.
Ganguly G; Chakrabarti S; Chatterjee U; Saso L
Drug Des Devel Ther; 2017; 11():797-810. PubMed ID: 28352155
[TBL] [Abstract][Full Text] [Related]
4. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease.
Tan SH; Karri V; Tay NWR; Chang KH; Ah HY; Ng PQ; Ho HS; Keh HW; Candasamy M
Biomed Pharmacother; 2019 Mar; 111():765-777. PubMed ID: 30612001
[TBL] [Abstract][Full Text] [Related]
5. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
Castrillo JI; Lista S; Hampel H; Ritchie CW
Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
[TBL] [Abstract][Full Text] [Related]
6. Network-Based Analysis for Uncovering Mechanisms Underlying Alzheimer's Disease.
Kikuchi M; Ogishima S; Mizuno S; Miyashita A; Kuwano R; Nakaya J; Tanaka H
Methods Mol Biol; 2016; 1303():479-91. PubMed ID: 26235086
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial retrograde signaling in the nervous system.
Hunt RJ; Bateman JM
FEBS Lett; 2018 Mar; 592(5):663-678. PubMed ID: 29086414
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.
Area-Gomez E; Guardia-Laguarta C; Schon EA; Przedborski S
J Clin Invest; 2019 Jan; 129(1):34-45. PubMed ID: 30601141
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks.
Castrillo JI; Oliver SG
Methods Mol Biol; 2016; 1303():3-48. PubMed ID: 26235058
[TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis of Parkinson's Disease and Alzheimer's Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes.
Wang Q; Li WX; Dai SX; Guo YC; Han FF; Zheng JJ; Li GH; Huang JF
J Alzheimers Dis; 2017; 56(4):1525-1539. PubMed ID: 28222515
[TBL] [Abstract][Full Text] [Related]
12. Unlocking Human Brain Metabolism by Genome-Scale and Multiomics Metabolic Models: Relevance for Neurology Research, Health, and Disease.
Sertbas M; Ulgen KO
OMICS; 2018 Jul; 22(7):455-467. PubMed ID: 30004841
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Common Molecular Basis in Alzheimer's and Parkinson's Diseases.
Rana P; Franco EF; Rao Y; Syed K; Barh D; Azevedo V; Ramos RTJ; Ghosh P
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366155
[TBL] [Abstract][Full Text] [Related]
14. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB
Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?
Macdonald R; Barnes K; Hastings C; Mortiboys H
Biochem Soc Trans; 2018 Aug; 46(4):891-909. PubMed ID: 30026371
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases.
Van der Schyf CJ
Drug Dev Res; 2016 Dec; 77(8):458-468. PubMed ID: 27813127
[TBL] [Abstract][Full Text] [Related]
17. miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases.
Sadlon A; Takousis P; Alexopoulos P; Evangelou E; Prokopenko I; Perneczky R
Trends Mol Med; 2019 Aug; 25(8):662-672. PubMed ID: 31221572
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase 2 in the spotlight: The link between mitochondria and neurodegeneration.
Deza-Ponzio R; Herrera ML; Bellini MJ; Virgolini MB; Hereñú CB
Neurotoxicology; 2018 Sep; 68():19-24. PubMed ID: 29936317
[TBL] [Abstract][Full Text] [Related]
19. Alternative cleavage and polyadenylation of genes associated with protein turnover and mitochondrial function are deregulated in Parkinson's, Alzheimer's and ALS disease.
Patel R; Brophy C; Hickling M; Neve J; Furger A
BMC Med Genomics; 2019 May; 12(1):60. PubMed ID: 31072331
[TBL] [Abstract][Full Text] [Related]
20. Protein Clustering and Interactome Analysis in Parkinson and Alzheimer's Diseases.
Rezaei-Tavirani M; Zamanian-Azodi M; Rajabi S; Masoudi-Nejad A; Rostami-Nejad M; Rahmatirad S
Arch Iran Med; 2016 Feb; 19(2):101-9. PubMed ID: 26838080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
